Track the DIASORIN SPA share price and the full insider trade history of the company, a listed issuer based in Italy. Shares are quoted on the IT market, under the supervision of Consob. Operating in the Health Care sector, DIASORIN SPA has recorded 13 public disclosures. Market capitalisation: €3.5bn. The latest transaction was reported on 23 July 2026 (Purchase). All data is openly available.
13
Insider Decl.
n/a
Thresholds
€151m
7 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate DIASORIN SPA Hold (neutral), based on 14 analysts. Average price target: €70.45.
33Σ signal
Buys €151mn/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 8,562 of 29,063 companies
61.7
score / 100
Value
58
Quality
66
FCF yld5.5%
Earn yld4.1%
EV/EBITDA12.5x
ROE9.2%
Gross mgn65%
Net mgn13%
Debt/EBITDA2.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
3 shares@ €66.960.0000% mcap0.0% of flowShareXMILISINISIN IT0003492391CONSOB:175961
13 of 13 declarations
Acerca de DIASORIN SPA
DIASORIN SPA es una empresa especializada en diagnóstico in vitro, que ofrece soluciones para la detección de enfermedades infecciosas y marcadores tumorales. Cotiza en el mercado XMIL.